Rhomboid shaped implants

Information

  • Patent Grant
  • 12239544
  • Patent Number
    12,239,544
  • Date Filed
    Thursday, May 27, 2021
    4 years ago
  • Date Issued
    Tuesday, March 4, 2025
    4 months ago
Abstract
A rhomboid shaped spinal implant may include a proximal surface that extends from a first lower end to a first upper end thereof a first distance, and a distal surface that extends from a second lower end to a second upper end thereof a second distance. The implant may include a superior surface that extends from the first upper end of the proximal surface to the second upper end of the distal surface a third distance, and an inferior surface that extends from the first lower end of the proximal surface to the second lower end of the distal surface a fourth distance. In various embodiments, the first distance is greater than the second distance, and the third distance is less than the fourth distance. In some embodiments, at least one bone screw aperture defines a trajectory extending in a direction substantially perpendicular to the superior and/or inferior surface.
Description
FIELD

The present technology is generally related to implants for use in a medical procedure related to the spine. In some embodiments, disclosed implants may have a rhomboid like shape and may be used in an anterior cervical discectomy and fusion (ACDF) procedure although other uses in other areas of the spine and other orthopedic uses are also contemplated.


BACKGROUND

Implants for the spine may be positioned between adjacent vertebrae of a patient include a superior endplate and an inferior endplate roughly having a rectangular and/or square configuration. Additionally, implants for the spine may include bone screw apertures extending through the superior endplate and/or inferior endplate for securing a corresponding bone screw into an adjacent vertebra.


SUMMARY

The techniques of this disclosure generally relate to an implant for the spine having a rhomboid like shape. A rhomboid or near-rhomboid shaped interbody as disclosed herein may more closely conform to the natural human anatomy of a disc space than conventional rectangular implants, particularly in the cervical area of the spine. Additionally, in various embodiments, the implant may, for example, orient a superior bone screw at an angle that is substantially or more closely approximately perpendicular with respect to a plane of the superior endplate. Similarly, the implant may, for example, orient an inferior bone screw at an angle that is substantially or more closely approximately perpendicular with respect to a plane of the inferior endplate.


In various embodiments, a spinal implant is disclosed. The spinal implant may include a body extending from a proximal surface to a distal surface in a proximal-to-distal direction, extending from a first lateral surface to a second lateral surface in a widthwise direction, and extending from a superior surface to an inferior surface in a vertical direction, for example. In various embodiments, the proximal surface extends from a first lower end thereof to a first upper end thereof a first distance, and the distal surface extends from a second lower end thereof to a second upper end thereof a second distance, for example. Additionally, in various embodiments, the superior surface extends from the first upper end of the proximal surface to the second upper end of the distal surface a third distance, the third distance being defined between a central endpoint of the first upper end of the proximal surface to a central endpoint of the second upper end of the distal surface, for example. Furthermore, in various embodiments, the inferior surface extends from the first lower end of the proximal surface to the second lower end of the distal surface a fourth distance, the fourth distance being defined by a central endpoint of the first lower end of the proximal surface to a central endpoint of the second lower end of the distal surface, for example. In some embodiments, the first distance is greater than the second distance, and the third distance is less than the fourth distance.


In various embodiments, a rhomboid or near-rhomboid shaped spinal implant is disclosed. The implant may include a body extending from a proximal surface to a distal surface in a proximal-to-distal direction, extending from a first lateral surface to a second lateral surface in a widthwise direction, and extending from a superior surface to an inferior surface in a vertical direction, for example. In various embodiments, the proximal surface is substantially planar, or curved, and defines a proximal plane, the distal surface is substantially planar, or curved, and defines a distal plane, the superior surface is substantially planar, or curved (e.g. convex) and defines a superior plane, and the inferior surface is substantially planar, or curved (e.g. convex), and defines an inferior plane, for example. In various embodiments, a first intersection of the proximal plane and the superior plane includes a first interior angle that is greater than 90 degrees, and a second intersection of the distal plane and the superior plane includes a second interior angle that is less than 90 degrees, for example. Additionally, in various embodiments, a third intersection of the proximal plane and the inferior plane includes a third interior angle that is less than 90 degrees, and a fourth intersection of the distal plane and the inferior plane includes a fourth interior angle that is greater than 90 degrees, for example.


The details of one or more aspects of the disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the techniques described in this disclosure will be apparent from the description and drawings, and from the claims.





BRIEF DESCRIPTION OF DRAWINGS


FIG. 1 is a perspective view of an implant.



FIG. 2A is a first side view of the implant of FIG. 1.



FIG. 2B is a second side view of the implant of FIG. 1.



FIG. 2C is a third side view of the implant of FIG. 1.



FIG. 2D is a fourth side view of the implant of FIG. 1.



FIG. 3 is an alternate perspective view of an implant.



FIG. 4 is a perspective view of an alternate implant.



FIG. 5 is an alternate perspective view of the implant of FIG. 4.



FIG. 6A is a side view of a unibody implant in a contracted configuration.



FIG. 6B is a side view of the implant of FIG. 6A in an expanded configuration.





DETAILED DESCRIPTION

Embodiments of the present disclosure relate generally, for example, to spinal interbody implants, and more particularly, to interbody implants that have a rhomboid like shape. Embodiments of the devices and methods are described below with reference to the Figures.


The following discussion omits or only briefly describes certain components, features and functionality related to medical implants, installation tools, and associated surgical techniques, which are apparent to those of ordinary skill in the art. It is noted that various embodiments are described in detail with reference to the drawings, in which like reference numerals represent like parts and assemblies throughout the several views, where possible. Reference to various embodiments does not limit the scope of the claims appended hereto because the embodiments are examples of the inventive concepts described herein. Additionally, any example(s) set forth in this specification are intended to be non-limiting and set forth some of the many possible embodiments applicable to the appended claims. Further, particular features described herein can be used in combination with other described features in each of the various possible combinations and permutations unless the context or other statements clearly indicate otherwise.


Terms such as “same,” “equal,” “planar,” “coplanar,” “parallel,” “perpendicular,” etc. as used herein are intended to encompass a meaning of exactly the same while also including variations that may occur, for example, due to manufacturing processes. The term “substantially” may be used herein to emphasize this meaning, particularly when the described embodiment has the same or nearly the same functionality or characteristic, unless the context or other statements clearly indicate otherwise.


Referring generally to FIGS. 1-3 a first embodiment of a spinal implant 100 is disclosed. Spinal implant 100 may have a general shape approximating the shape of a rhomboid, for example. In a side view, example implants 100 may be shaped like a parallelogram in which adjacent sides are of unequal lengths and interior angles between the adjacent sides are non-right angled, i.e., have an approximately rhomboid shaped configuration. Example implants 100 may be of the expandable type or the non-expandable type. Those that do expand may form a general shape approximating the shape of a rhomboid in the expanded configuration, at least in cross section. Various surfaces of the implant 100 may be planar and/or concave, convex, undulating, etc. At least one advantage of implant 100 having a cross sectional shape that generally approximates a rhomboid is that implant 100 may better or more closely conform to and/or approximate a disc space of a patient, for example. For example, the cervical area of the spine may include disc spaces that are shaped like a trapezoid and a rhombus shaped implant may better support the disc space than a conventional square or rectangular shaped implant. Disclosed implants facilitate the maximization of endplate coverage within the disc space without protruding anteriorly, posteriorly, and/or into the spinal canal, for example.


Implant 100 may be a unibody implant formed of a monolithic structure, or body, for example. Implant 100 may include a body having six dominant surfaces or sides, for example. Implant 100 may include proximal surface 110, first lateral surface 120, second lateral surface 130, distal surface 140, superior surface 150, and inferior surface 160. In some embodiments, superior surface 150 may be a surface of a superior endplate and inferior surface 160 may be a surface of an inferior endplate. The body of implant 100 may extend from proximal surface 110 to distal surface 140 in a proximal-to-distal direction A-A, extend from first lateral surface 120 to a second lateral surface 130 in a widthwise direction C-C, and extend from a superior surface 150 to an inferior surface 160 in a vertical direction B-B, for example (see FIG. 2A). In the example embodiment of FIG. 1, it is shown that a first bone screw aperture 101 extends through the superior surface 150 and a second bone screw aperture 102 extends through the inferior surface 160.


Referring to FIG. 2A, the proximal surface 110 may extend from a first lower end 112 to a first upper end 114, and the distal surface 140 may extend from a second lower end 142 to a second upper end 144, for example. The superior surface 150 may extend from a first proximal end 152 thereof, to a first distal end 154 thereof, and the inferior surface 160 may extend from a second proximal end 162 thereof to a second distal end 164 thereof, for example. In various embodiments, the edges of implant 100 may be chamfered, angled, rounded, and/or smooth. For example, the edge of implant 100 where proximal surface 110 meets the superior surface 150 may comprise a chamfered edge including both first upper end 114 of proximal surface 110 and end 152 of superior surface 150, for example. Similarly, the edge of implant 100 where distal surface 140 meets the superior surface 150 may comprise a chamfered edge including both second upper end 144 of distal surface 140 and end 154 of superior surface 150, for example. Likewise, the edge of implant 100 where proximal surface 110 meets inferior surface 160 may comprise a chamfered edge including both first lower end 112 of proximal surface 110 and end 162 of inferior surface 160, for example. Similarly, the edge of implant 100 where distal surface 140 meets the inferior surface 160 may comprise a chamfered edge including both second lower end 142 of distal surface 140 and end 164 of inferior surface 160, for example. In other embodiments, a chamfered edge may not be provided, or may be selectively provided, and the various edges may be the same, substantially the same, and/or similar as described above. Furthermore, in some embodiments, various surfaces described above having edges adjoining the chamfered edge may be coextensive.


In some embodiments, a transition from one surface to the next adjoining surface may not include a hard edge delimiting the two surfaces. For example, a transition from a dominant face of one surface to the next adjoining dominant face of another surface may be a smooth and relatively subtle transition. The smooth and/or relatively subtle transition may be a chamfered edge, a curved edge, a bulbous edge, or the like, for example. In some embodiments, the superior surface 150 may be convex and the curvature of the superior surface 150 may match the curvature of the endplate of an adjacent vertebrae and the transition from the superior surface 150 to the first lateral surface 120 and second lateral surface 130 may be a smoother and/or gentler transition than what is shown in FIG. 2A.


In FIG. 2B, a spinal implant 100 is illustrated. FIG. 2B is the same side view of implant 100 as FIG. 2A although with different geometrical properties emphasized. For example, a first distance D1 of proximal surface 110 may be understood as a distance from first lower end 112 to first upper end 114 in the vertical direction B-B. For example, a first point on first lower end 112 that is laterally aligned in the widthwise direction C-C with a second point on first upper end 114, i.e., a corresponding point. A second distance D2 of distal surface 140 may be understood as a distance from second lower end 142 to second upper end 144 in the vertical direction B-B. For example, a third point on second lower end 142 that is laterally aligned in the widthwise direction C-C with a fourth point on second upper end 144.


Similarly, a third distance D3 of superior surface 150 may be understood as a distance from end 152 to end 154 (and/or also from first upper end 114 to second upper end 144) in the proximal-to-distal direction A-A. For example, a fifth point on end 152 that is laterally aligned in the widthwise direction C-C with a sixth point on first upper end 114, i.e., a corresponding point. A fourth distance D4 of inferior surface 160 may be understood as a distance from end 162 to end 164. For example, a seventh point on end 162 that is laterally aligned in the widthwise direction C-C with an eighth point on end 164. In various embodiments, the fourth distance D4 is greater than the first distance D1, second distance D2, and third distance D3, for example. Additionally, the third distance may be greater than the first distance D1 and the second distance D2. Furthermore, the first distance D1 may be greater than the second distance D2. This relationship of distances may result in an implant 100 having a rhomboid and/or substantially rhomboid like shape. For example, in the side view of FIG. 2B the implant 100 is shaped like a rhomboid.


In various embodiments, the proximal surface 110, first lateral surface 120, second lateral surface 130, distal surface 140, superior surface 150, and inferior surface 160 may be substantially planar. In some embodiments, the proximal surface 110, first lateral surface 120, second lateral surface 130, distal surface 140, superior surface 150, and inferior surface 160 may include a portion thereof that may be substantially planar. For example, an end portion thereof and/or a central medial portion thereof. As illustrated in FIG. 2C, an extension of the dominant contour (and/or plane) of inferior surface 160 may intersect with an extension of the dominant contour of proximal surface 110 at point 110-160 and form a first acute angle α1, i.e., an angle less than 90 degrees. Similarly, an extension of the dominant contour of inferior surface 160 may intersect with an extension of the dominant contour of distal surface 140 at point 140-160 and form a first obtuse angle β1, i.e., an angle greater than 90 degrees and less than 180 degrees. Additionally, an extension of the dominant contour of superior surface 150 may intersect with an extension of the dominant contour of proximal surface 110 at point 110-150 and form a second obtuse angle β2. Furthermore, an extension of the dominant contour of superior surface 150 may intersect with an extension of the dominant contour of distal surface 140 at point 140-150 and form a second acute angle α2. In various embodiments, the above angles may be established at any point where the respective planes as explained above interest. Although an outside angle is labeled, those with skill in the art will appreciate that the labeled outside angle directly corresponds to the interior angle as well. Additionally, in some embodiments, the above angles are established at a point or points corresponding in space to the lateral ends adjacent the first lateral surface 120, and/or alternatively adjacent the second lateral surface 130, for example. Furthermore, the above angles may be established at a junction of the corresponding surfaces and correspond to an internal angle between the respective surfaces in the same, similar, and/or substantially the same way.


Consistent with the above disclosure, those with skill in the art will understand that the overall shape of implant 100 may be a generally rhomboid like shape when viewed from the side, and/or in a side view of a cross section through implant 100 in the proximal-to-distal direction and that the particular angles shown in the example embodiments may be different. For example, an exact angle between the edge portion of the superior surface 150 and the edge portion of the proximal surface 110 is not necessarily “obtuse” but rather the dominant contour of the superior surface 150 and the dominant contour of the proximal surface 110 intersect in 3D space to form an obtuse angle. Similarly, an exact angle between the edge portion of the inferior surface 160 and the proximal surface 110 is not necessarily “acute” but rather the dominant contour of the inferior surface 160 and the dominant contour of the proximal surface 110 intersect in 3D space to form an acute angle. In some embodiments, a dominant contour of a particular surface may be calculated as an average of various discrete contours of the same surface. For example, a dominant contour of the superior surface 150 may be calculated by taking an average of ten contour lines extending in a parallel direction from the proximal side of the superior surface 150 to the distal side of the superior surface 150, for example. Furthermore, a similar edge-to-edge averaging of contours of a different surface may be performed in like manner on any of the various surfaces discussed herein with more or less contour lines, e.g., any number of contour lines from about 2 to about 100 depending solely on the precision required for the target position of implant 100 between two particular vertebrae of a patient.


In the example embodiment of FIG. 2D, it is shown that a first bone screw aperture 101 extends through the superior surface 150 in a superior direction that is substantially parallel to the vertical direction, for example. Similarly, it is shown that a second bone screw aperture 102 extends through the inferior surface 160 in an inferior direction that is substantially parallel to the vertical direction. First bone screw aperture 101 may be formed at a corner of implant 100 formed partly in the proximal surface 110 and first lateral surface 120, for example. First bone screw aperture 101 may comprise a circular through hole, a tapering through hole, or a conical through hole that orients a first bone screw 170 in a pre-stablished trajectory 170t, for example. In various embodiments, trajectory 170t may project away from the superior surface 150 at an angle Θ1 that is approximately and/or substantially perpendicular to superior surface 150, e.g., about 80-90 degrees. It is contemplated that trajectory 170t may be angled slightly in the distal direction and/or towards a medial portion of implant 100 as well. Similarly, second bone screw aperture 102 may comprise a circular through hole, a tapering through hole, or a conical through hole that orients a second bone screw 171 in a pre-stablished trajectory 171t, for example. In various embodiments, trajectory 171t may project away from the inferior surface 160 at an angle Θ2 that is approximately and/or substantially perpendicular to inferior surface 160, e.g., about 80-90 degrees. It is contemplated that trajectory 171t may be angled slightly in the distal direction and/or towards a medial portion of implant 100 as well. In this way, trajectories 170t, 171t may converge towards a central portion of implant 100 from the proximal side of implant 100 towards the distal side of implant 100, for example. At least one advantage of bone screw apertures 101, 102 defining trajectories 170t, 171t as explained above is that the substantially perpendicular orientation increases the relative amount of shear loading the bone screws 170, 171 can absorb across the disc space compared to an axial force applied to the bone screws 170, 171, for example. Additionally, in various embodiments, the substantially or approximately perpendicular orientation facilitates the bone screws 170, 171 being secured to patient anatomy predominantly, mostly, and/or entirely within the anterior rim and/or cortical bone, which is generally considered a relatively strong section of bone.



FIG. 3 is an additional perspective view of implant 100 showing the features and characteristics explained above. Additionally, FIG. 3 illustrates a bone graft aperture 103 that may be formed in the center of implant 100, for example in a medial position. Bone graft aperture 103 may extend through the superior surface 150 and inferior surface 160 and be shaped like a square, rectangle, oval, circle, or the like.



FIGS. 4-5 are perspective views of an alternate implant 200. Alternate implant 200 may have the same, similar, and/or substantially the same characteristics as explained above with respect to implant 100. Additionally, proximal surface 110 may include a relatively wide curved surface 115 (also referred to as a scallop 115), for example. In various embodiments, the proximal surface 110 may be substantially defined by a first curved surface 115 that arcs inward with respect to the distal surface 140 and extends in a vertical direction from the first lower end 112 to the first upper end 114, for example. Similarly, in various embodiments, distal surface 140 may include a relatively wide curved surface 145 (also referred to as a scallop 145), for example. In various embodiments, the distal surface 140 may be substantially defined by a second curved surface 145 that arcs inward with respect to the proximal surface 110 and extends in a vertical direction B-B from the first lower end 112 to the first upper end 114, for example. At least one advantage of curved surfaces 115, 145 is that they may be curved to avoid delicate anatomy such as the spinal cord and/or other sensitive patient tissue.


An additional advantage of curved surfaces 115, 145 is that they may accommodate and/or conform to additional medical hardware, such as an anterior plate for bone screws or the like (not illustrated). For example, curved surface 115 may allow access to install and/or tighten the bone screws to the adjacent vertebrae with a retaining plate in place. For example still, the curved surface 115 may allow the anterior plate to be positioned above the anterior face of the patient vertebrae a first distance and allow eyelets to be positioned proud by a second distance. In some embodiments, the first and second distances may be substantially the same which may allow the bone screws to be oriented perpendicular and/or substantially perpendicular to the patient VB which may allow the bone screws to be secured to cortical bone because the anterior plate has positioned the bone screws far enough in an anterior direction, for example.



FIG. 6A is a side view of a unibody implant 300 in a contracted configuration and FIG. 6B is a side view of the unibody implant 300 in an expanded configuration. Unibody implant 300 may include the same, substantially the same, and/or similar features and characteristics as described in detail in U.S. application Ser. No. 17/246,968, titled Unibody Dual Expanding Interbody Implant, the entire contents of which are incorporated herein. Additionally, as illustrated, unibody implant 300 approximates a rhomboid like shape (in cross section). In some embodiments, unibody implant 300 may approximate a rhomboid like shape in an expanded position, a collapsed position, and/or an intermediate position. Accordingly, various unibody implants 300 may have the same advantages as disclosed herein with respect to implants 100, and 200. Similarly, the various implants disclosed in U.S. application Ser. No. 17/307,578, titled Externally Driven Expandable Interbody and Related Methods; and U.S. application Ser. No. 17/331,058, titled Dual Wedge Implant may also have a rhomboid like shape.


It should be understood that various aspects disclosed herein may be combined in different combinations than the combinations specifically presented in the description and accompanying drawings. For example, features, functionality, and components from one embodiment may be combined with another embodiment and vice versa unless the context clearly indicates otherwise. Similarly, features, functionality, and components may be omitted unless the context clearly indicates otherwise. It should also be understood that, depending on the example, certain acts or events of any of the processes or methods described herein may be performed in a different sequence, may be added, merged, or left out altogether (e.g., all described acts or events may not be necessary to carry out the techniques).


Unless otherwise specifically defined herein, all terms are to be given their broadest possible interpretation including meanings implied from the specification as well as meanings understood by those skilled in the art and/or as defined in dictionaries, treatises, etc. It must also be noted that, as used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless otherwise specified, and that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof.

Claims
  • 1. A spinal implant, comprising: a body extending from a proximal surface to a distal surface in a proximal-to-distal direction, extending from a first lateral surface to a second lateral surface in a widthwise direction, and extending from a superior surface to an inferior surface in a vertical direction,wherein: the proximal surface extends from a first lower end thereof to a first upper end thereof a first distance,the distal surface extends from a second lower end thereof to a second upper end thereof a second distance,the superior surface extends from the first upper end of the proximal surface to the second upper end of the distal surface a third distance, the third distance being defined between a central endpoint of the first upper end of the proximal surface to a central endpoint of the second upper end of the distal surface,the inferior surface extends from the first lower end of the proximal surface to the second lower end of the distal surface a fourth distance, the fourth distance being defined by a central endpoint of the first lower end of the proximal surface to a central endpoint of the second lower end of the distal surface,the first distance is greater than the second distance,the third distance is less than the fourth distance,in a side view, a first interior angle formed by an intersection of a dominant extension of a side edge of the proximal surface and a dominant extension of a side edge of the inferior surface defines a first acute angle,in the side view, a second interior angle formed by an intersection of the dominant extension of the side edge of the proximal surface and a dominant extension of a side edge of the superior surface defines a first obtuse angle,in the side view, a third interior angle formed by an intersection of a dominant extension of a side edge of the distal surface and the dominant extension of the side edge of the superior surface defines a second acute angle, andin the side view, a fourth interior angle formed by an intersection of the dominant extension of the side edge of the distal surface and a dominant extension of the side edge of the inferior surface defines a second obtuse angle.
  • 2. The implant of claim 1, wherein the fourth distance is greater than the first distance, the second distance, and the third distance.
  • 3. The implant of claim 2, wherein the third distance is greater than the second distance and first distance.
  • 4. The implant of claim 1, wherein, in a side view, the body is in a substantially rhomboid configuration.
  • 5. The implant of claim 1, wherein the body is a unitary body.
  • 6. The implant of claim 1, wherein the body is an expandable body and in an expanded configuration the body is in a substantially rhomboid configuration.
  • 7. The implant of claim 1, wherein a centrally disposed graft aperture extends through the superior surface and the inferior surface in the vertical direction.
  • 8. The implant of claim 1, further comprising at least one of: a first bone screw aperture defining a first trajectory for a first bone screw and/or a second bone screw aperture defining a second trajectory for a second bone screw.
  • 9. The implant of claim 8, wherein the superior surface is substantially planar and the first trajectory extends away from the superior surface in a superior direction that is substantially perpendicular to the superior surface.
  • 10. The implant of claim 8, wherein the inferior surface is substantially planar and the second trajectory extends away from the inferior surface in an inferior direction that is substantially perpendicular to the inferior surface.
  • 11. The implant of claim 8, wherein: the superior surface is substantially planar and the first trajectory extends away from the superior surface in a superior direction that is substantially perpendicular to the superior surface, andthe inferior surface is substantially planar and the second trajectory extends away from the inferior surface in an inferior direction that is substantially perpendicular to the inferior surface.
  • 12. The implant of claim 1, wherein: the proximal surface is substantially planar and defines a proximal plane,the distal surface is substantially planar and defines a distal plane,the superior surface is substantially planar and defines a superior plane, andthe inferior surface is substantially planar and defines an inferior plane.
  • 13. The implant of claim 1, wherein: the proximal surface is substantially defined by a first curved surface that arcs inward with respect to the distal surface and extends in the vertical direction from the first lower end of the proximal surface to the first upper end of the proximal surface, andthe distal surface is substantially defined by a second curved surface that arcs inward with respect to the proximal surface and extends in the vertical direction from the second lower end of the distal surface to the second upper end of the distal surface.
  • 14. An approximately rhomboid shaped spinal implant, comprising: a body extending from a proximal surface to a distal surface in a proximal-to-distal direction, extending from a first lateral surface to a second lateral surface in a widthwise direction, and extending from a superior surface to an inferior surface in a vertical direction,wherein: the proximal surface is substantially planar and defines a proximal plane,the distal surface is substantially planar and defines a distal plane,the superior surface is substantially planar and defines a superior plane,the inferior surface is substantially planar and defines an inferior plane,a first intersection of the proximal plane and the superior plane comprises a first interior angle that is greater than 90 degrees,a second intersection of the distal plane and the superior plane comprises a second interior angle that is less than 90 degrees,a third intersection of the proximal plane and the inferior plane comprises a third interior angle that is less than 90 degrees, anda fourth intersection of the distal plane and the inferior plane comprises a fourth interior angle that is greater than 90 degrees.
  • 15. The implant of claim 14, further comprising at least one of: a first bone screw aperture defining a first trajectory for a first bone screw and/or a second bone screw aperture defining a second trajectory for a second bone screw.
  • 16. The implant of claim 15, wherein first trajectory extends away from the superior plane in a superior direction that is substantially perpendicular to the superior plane and the second target trajectory extends away from the inferior plane in an inferior direction that is substantially perpendicular to the inferior plane.
Priority Claims (2)
Number Date Country Kind
PCT/IB2020/000942 Nov 2020 WO international
PCT/IB2020/000953 Nov 2020 WO international
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation in part of U.S. application Ser. No. 17/246,968, titled Unibody Dual Expanding Interbody Implant, filed May 3, 2021; U.S. application Ser. No. 17/307,578 titled Externally Driven Expandable Interbody and Related Methods, filed May 4, 2021; and U.S. application Ser. No. 17/331,058, titled Dual Wedge Implant, filed May 26, 2021. The entire disclosure of each is incorporated herein in its entirety.

US Referenced Citations (1009)
Number Name Date Kind
1677337 Grove Jul 1928 A
3847154 Nordin Nov 1974 A
4401112 Rezaian Aug 1983 A
4553273 Wu Nov 1985 A
4636217 Ogilvie et al. Jan 1987 A
4716894 Lazzeri et al. Jan 1988 A
4759769 Hedman et al. Jul 1988 A
5059193 Kuslich Oct 1991 A
5171278 Pisharodi Dec 1992 A
5228811 Potter Jul 1993 A
5284483 Johnson et al. Feb 1994 A
5336223 Rogers Aug 1994 A
5390683 Pisharodi Feb 1995 A
5522899 Michelson Jun 1996 A
5554191 Lahille et al. Sep 1996 A
5575790 Chen et al. Nov 1996 A
5609635 Michelson Mar 1997 A
5653762 Pisharodi Aug 1997 A
5653763 Errico et al. Aug 1997 A
5658336 Pisharodi Aug 1997 A
5665122 Kambin Sep 1997 A
5693100 Pisharodi Dec 1997 A
5697977 Pisharodi Dec 1997 A
5702391 Lin Dec 1997 A
5702453 Rabbe et al. Dec 1997 A
5702455 Saggar Dec 1997 A
5797918 McGuire et al. Aug 1998 A
5800550 Sertich Sep 1998 A
5865848 Baker Feb 1999 A
5893890 Pisharodi Apr 1999 A
5931777 Sava Aug 1999 A
5941885 Jackson Aug 1999 A
5971987 Huxel et al. Oct 1999 A
5980522 Koros et al. Nov 1999 A
6045579 Hochshuler et al. Apr 2000 A
6074343 Nathanson et al. Jun 2000 A
6080193 Hochshuler et al. Jun 2000 A
6099531 Bonutti Aug 2000 A
6102949 Biedermann et al. Aug 2000 A
6102950 Vaccaro Aug 2000 A
6106557 Robioneck et al. Aug 2000 A
6113638 Williams et al. Sep 2000 A
6117174 Nolan Sep 2000 A
6132465 Ray et al. Oct 2000 A
6159211 Boriani et al. Dec 2000 A
6159244 Suddaby Dec 2000 A
6176882 Biedermann et al. Jan 2001 B1
6179873 Zientek Jan 2001 B1
6190414 Young et al. Feb 2001 B1
6193757 Foley et al. Feb 2001 B1
6217579 Koros Apr 2001 B1
6245108 Biscup Jun 2001 B1
6309421 Pisharodi Oct 2001 B1
6342074 Simpson Jan 2002 B1
6371989 Chauvin et al. Apr 2002 B1
6395031 Foley et al. May 2002 B1
6423063 Bonutti Jul 2002 B1
6432106 Fraser Aug 2002 B1
6436140 Liu et al. Aug 2002 B1
6443989 Jackson Sep 2002 B1
6443990 Aebi et al. Sep 2002 B1
6454806 Cohen et al. Sep 2002 B1
6454807 Jackson Sep 2002 B1
6461359 Tribus et al. Oct 2002 B1
6475218 Gournay et al. Nov 2002 B2
6491724 Ferree Dec 2002 B1
6520991 Huene Feb 2003 B2
6520993 James et al. Feb 2003 B2
6524238 Velikaris et al. Feb 2003 B2
6527803 Crozet et al. Mar 2003 B1
6562074 Gerbec et al. May 2003 B2
6576016 Hochshuler et al. Jun 2003 B1
6623525 Ralph et al. Sep 2003 B2
6629998 Lin Oct 2003 B1
6635086 Lin Oct 2003 B2
6648917 Gerbec et al. Nov 2003 B2
6676703 Biscup Jan 2004 B2
6685742 Jackson Feb 2004 B1
6723126 Berry Apr 2004 B1
6770096 Bolger et al. Aug 2004 B2
6773460 Jackson Aug 2004 B2
6821298 Jackson Nov 2004 B1
6835206 Jackson Dec 2004 B2
6849093 Michelson Feb 2005 B2
6852129 Gerbec et al. Feb 2005 B2
6863673 Gerbec et al. Mar 2005 B2
6923814 Hildebrand et al. Aug 2005 B1
6926737 Jackson Aug 2005 B2
6953477 Berry Oct 2005 B2
6964687 Bernard et al. Nov 2005 B1
6974480 Messerli et al. Dec 2005 B2
6984234 Bray Jan 2006 B2
7112222 Fraser et al. Sep 2006 B2
7135043 Nakahara et al. Nov 2006 B2
7137997 Paul Nov 2006 B2
7172627 Fiere et al. Feb 2007 B2
7188626 Foley et al. Mar 2007 B2
7204853 Gordon et al. Apr 2007 B2
7232464 Mathieu et al. Jun 2007 B2
7238203 Bagga et al. Jul 2007 B2
7255700 Kaiser et al. Aug 2007 B2
7316532 Matthys-Mark Jan 2008 B2
7316714 Gordon et al. Jan 2008 B2
7407483 Perez-Cruet et al. Aug 2008 B2
7481766 Lee et al. Jan 2009 B2
7491168 Raymond et al. Feb 2009 B2
7537565 Bass May 2009 B2
7618456 Mathieu et al. Nov 2009 B2
7625394 Molz, IV et al. Dec 2009 B2
7635366 Abdou Dec 2009 B2
7637909 Lechot et al. Dec 2009 B2
7655046 Dryer et al. Feb 2010 B2
7678148 Peterman Mar 2010 B2
7703727 Selness Apr 2010 B2
7708778 Gordon et al. May 2010 B2
7708779 Edie et al. May 2010 B2
7727280 McLuen Jun 2010 B2
7753958 Gordon et al. Jul 2010 B2
7780594 Hutton Aug 2010 B2
7806932 Webb et al. Oct 2010 B2
7815682 Peterson et al. Oct 2010 B1
7819801 Miles et al. Oct 2010 B2
7824428 Mikkonen et al. Nov 2010 B2
7828849 Lim Nov 2010 B2
7846167 Garcia et al. Dec 2010 B2
7846207 Lechmann et al. Dec 2010 B2
7850731 Brittan et al. Dec 2010 B2
7850733 Baynham et al. Dec 2010 B2
7862616 Lechmann et al. Jan 2011 B2
7875076 Mathieu et al. Jan 2011 B2
7883542 Zipnick Feb 2011 B2
7892173 Miles et al. Feb 2011 B2
7909869 Gordon et al. Mar 2011 B2
7914559 Carls et al. Mar 2011 B2
7967821 Sicvol et al. Jun 2011 B2
7981031 Frasier et al. Jul 2011 B2
8016836 Corrao et al. Sep 2011 B2
8062375 Glerum et al. Nov 2011 B2
8105382 Olmos et al. Jan 2012 B2
8118870 Gordon et al. Feb 2012 B2
8118871 Gordon et al. Feb 2012 B2
8123810 Gordon et al. Feb 2012 B2
8147550 Gordon et al. Apr 2012 B2
8172903 Gordon et al. May 2012 B2
8182539 Tyber et al. May 2012 B2
8257442 Edie et al. Sep 2012 B2
8262570 White et al. Sep 2012 B2
8262662 Beardsley et al. Sep 2012 B2
8262710 Freedman et al. Sep 2012 B2
8287597 Pimenta et al. Oct 2012 B1
8303498 Miles et al. Nov 2012 B2
8303658 Peterman Nov 2012 B2
8303663 Jimenez et al. Nov 2012 B2
8317866 Palmatier et al. Nov 2012 B2
8323185 Perez-Cruet et al. Dec 2012 B2
8328872 Duffield et al. Dec 2012 B2
8343048 Warren, Jr. Jan 2013 B2
8353826 Weiman Jan 2013 B2
8355780 Miles et al. Jan 2013 B2
8382842 Greenhalgh et al. Feb 2013 B2
8388527 Miles et al. Mar 2013 B2
8398713 Weiman Mar 2013 B2
8403990 Dryer et al. Mar 2013 B2
8419797 Biedermann et al. Apr 2013 B2
8425528 Berry et al. Apr 2013 B2
8435298 Weiman May 2013 B2
8480576 Sandhu Jul 2013 B2
8496706 Ragab et al. Jul 2013 B2
8500634 Miles et al. Aug 2013 B2
8506635 Palmatier et al. Aug 2013 B2
8517935 Marchek et al. Aug 2013 B2
8518120 Glerum et al. Aug 2013 B2
8535380 Greenhalgh et al. Sep 2013 B2
8550994 Miles et al. Oct 2013 B2
8556808 Miles et al. Oct 2013 B2
8556979 Glerum et al. Oct 2013 B2
8579809 Parker Nov 2013 B2
8579898 Prandi et al. Nov 2013 B2
8579979 Edie et al. Nov 2013 B2
8579981 Lim et al. Nov 2013 B2
8602984 Raymond et al. Dec 2013 B2
8608785 Reed et al. Dec 2013 B2
8628576 Triplett et al. Jan 2014 B2
8628578 Miller et al. Jan 2014 B2
8632595 Weiman Jan 2014 B2
8641768 Duffield et al. Feb 2014 B2
8647386 Gordon et al. Feb 2014 B2
8663329 Ernst Mar 2014 B2
8668419 Hardt et al. Mar 2014 B2
8668715 Sandhu Mar 2014 B2
8679183 Glerum et al. Mar 2014 B2
8685095 Miller et al. Apr 2014 B2
8685098 Glerum et al. Apr 2014 B2
8696559 Miles et al. Apr 2014 B2
8709083 Duffield et al. Apr 2014 B2
8709085 Lechmann et al. Apr 2014 B2
8709086 Glerum Apr 2014 B2
8715285 Lewis et al. May 2014 B2
8715353 Bagga et al. May 2014 B2
8740983 Arnold et al. Jun 2014 B1
8753271 Miles et al. Jun 2014 B1
8753396 Hockett et al. Jun 2014 B1
8764649 Miles et al. Jul 2014 B2
8771360 Jimenez et al. Jul 2014 B2
8778025 Ragab et al. Jul 2014 B2
8778027 Medina Jul 2014 B2
8795366 Varela Aug 2014 B2
8808305 Kleiner Aug 2014 B2
8827902 Dietze, Jr. et al. Sep 2014 B2
8828085 Jensen Sep 2014 B1
8840668 Donahoe et al. Sep 2014 B1
8845731 Weiman Sep 2014 B2
8845732 Weiman Sep 2014 B2
8845734 Weiman Sep 2014 B2
8852252 Venturini et al. Oct 2014 B2
8852282 Farley et al. Oct 2014 B2
8864833 Glerum et al. Oct 2014 B2
8882813 Jones et al. Nov 2014 B2
8888853 Glerum et al. Nov 2014 B2
8894708 Thalgott et al. Nov 2014 B2
8894711 Varela Nov 2014 B2
8894712 Varela Nov 2014 B2
8906095 Christensen et al. Dec 2014 B2
8920500 Pimenta et al. Dec 2014 B1
8926704 Glerum et al. Jan 2015 B2
8936641 Cain Jan 2015 B2
8940049 Jimenez et al. Jan 2015 B1
8968363 Weiman et al. Mar 2015 B2
8986344 Sandhu Mar 2015 B2
8992425 Karpowicz et al. Mar 2015 B2
8992544 Sasing Mar 2015 B2
9005292 Melamed Apr 2015 B2
9005293 Moskowitz et al. Apr 2015 B2
9005295 Kueenzi et al. Apr 2015 B2
9017412 Wolters et al. Apr 2015 B2
9034045 Davenport et al. May 2015 B2
9050146 Woolley et al. Jun 2015 B2
9050194 Thibodeau Jun 2015 B2
9060877 Kleiner Jun 2015 B2
9072548 Matityahu Jul 2015 B2
9072563 Garcia et al. Jul 2015 B2
9084591 Reglos et al. Jul 2015 B2
9113854 Ellman Aug 2015 B2
9119730 Glerum et al. Sep 2015 B2
9125757 Weiman Sep 2015 B2
9132021 Mermuys et al. Sep 2015 B2
9138217 Smith et al. Sep 2015 B2
9138330 Hansell et al. Sep 2015 B2
9138331 Aferzon Sep 2015 B2
9149367 Davenport et al. Oct 2015 B2
9155628 Glerum et al. Oct 2015 B2
9155631 Seifert et al. Oct 2015 B2
9161841 Kana et al. Oct 2015 B2
9179903 Cianfrani et al. Nov 2015 B2
9179952 Biedermann et al. Nov 2015 B2
9186193 Kleiner et al. Nov 2015 B2
9186258 Davenport et al. Nov 2015 B2
9192482 Pimenta et al. Nov 2015 B1
9192483 Radcliffe et al. Nov 2015 B1
9198772 Weiman Dec 2015 B2
9204972 Weiman et al. Dec 2015 B2
9204974 Glerum et al. Dec 2015 B2
9211194 Bagga et al. Dec 2015 B2
9211196 Glerum et al. Dec 2015 B2
9216095 Glerum et al. Dec 2015 B2
9226836 Glerum Jan 2016 B2
9233007 Sungarian et al. Jan 2016 B2
9233009 Gray et al. Jan 2016 B2
9233010 Thalgott et al. Jan 2016 B2
9259327 Niemiec et al. Feb 2016 B2
9271846 Lim et al. Mar 2016 B2
9308099 Triplett et al. Apr 2016 B2
9320610 Alheidt et al. Apr 2016 B2
9351845 Pimenta et al. May 2016 B1
9351848 Glerum et al. May 2016 B2
9357909 Perez-Cruet et al. Jun 2016 B2
9358126 Glerum et al. Jun 2016 B2
9358127 Duffield et al. Jun 2016 B2
9358128 Glerum et al. Jun 2016 B2
9358129 Weiman Jun 2016 B2
9364341 Gowan Jun 2016 B2
9364343 Duffield et al. Jun 2016 B2
9370434 Weiman Jun 2016 B2
9370435 Walkenhorst et al. Jun 2016 B2
9381008 Thornburg Jul 2016 B2
9386916 Predick et al. Jul 2016 B2
9387092 Mermuys et al. Jul 2016 B2
9402673 Cormier et al. Aug 2016 B2
9402739 Weiman et al. Aug 2016 B2
9408596 Blain Aug 2016 B2
9408708 Greenhalgh Aug 2016 B2
9414828 Abidin et al. Aug 2016 B2
9414934 Cain Aug 2016 B2
9414937 Carlson et al. Aug 2016 B2
9421110 Masson et al. Aug 2016 B2
9427331 Arnin Aug 2016 B2
9445919 Palmatier et al. Sep 2016 B2
9452063 Glerum et al. Sep 2016 B2
9456903 Glerum et al. Oct 2016 B2
9456906 Gray et al. Oct 2016 B2
9468405 Miles et al. Oct 2016 B2
9474622 McLaughlin et al. Oct 2016 B2
9474625 Weiman Oct 2016 B2
9480573 Perloff et al. Nov 2016 B2
9480576 Pepper et al. Nov 2016 B2
9480579 Davenport et al. Nov 2016 B2
9486133 Lee et al. Nov 2016 B2
9486325 Davenport et al. Nov 2016 B2
9486327 Martynova et al. Nov 2016 B2
9486328 Jimenez et al. Nov 2016 B2
9492287 Glerum et al. Nov 2016 B2
9492288 Wagner et al. Nov 2016 B2
9492289 Davenport et al. Nov 2016 B2
9498349 Patterson et al. Nov 2016 B2
9510954 Glerum et al. Dec 2016 B2
9517098 Anderson Dec 2016 B2
9522070 Flower et al. Dec 2016 B2
9526620 Slivka et al. Dec 2016 B2
9526625 Cain Dec 2016 B2
9532821 Moskowitz et al. Jan 2017 B2
9539103 McLaughlin et al. Jan 2017 B2
9539108 Glerum et al. Jan 2017 B2
9545320 Padovani et al. Jan 2017 B2
9549723 Hynes et al. Jan 2017 B2
9549824 McAfee Jan 2017 B2
9561116 Weiman et al. Feb 2017 B2
9566163 Suddaby et al. Feb 2017 B2
9566166 Parry et al. Feb 2017 B2
9566168 Glerum et al. Feb 2017 B2
9572560 Mast et al. Feb 2017 B2
9572677 Davenport et al. Feb 2017 B2
9572681 Mathieu et al. Feb 2017 B2
9579124 Gordon et al. Feb 2017 B2
9579139 Cormier et al. Feb 2017 B2
9579213 Bal et al. Feb 2017 B2
9585649 Blain et al. Mar 2017 B2
9585762 Suddaby et al. Mar 2017 B2
9585766 Robinson Mar 2017 B2
9585767 Robinson Mar 2017 B2
9592129 Slivka et al. Mar 2017 B2
9597195 Cain Mar 2017 B2
9603643 Reed et al. Mar 2017 B2
9603713 Moskowitz et al. Mar 2017 B2
9603717 Ibarra et al. Mar 2017 B2
9615818 Baudouin et al. Apr 2017 B2
9615936 Duffield et al. Apr 2017 B2
9622732 Martinelli et al. Apr 2017 B2
9622875 Moskowitz et al. Apr 2017 B2
9622876 Greenhalgh et al. Apr 2017 B1
9629729 Grimberg, Jr. et al. Apr 2017 B2
9636097 Bass May 2017 B2
9642720 Radcliffe et al. May 2017 B2
9649198 Wolters et al. May 2017 B2
9655746 Seifert May 2017 B2
9655747 Glerum et al. May 2017 B2
9662224 Weiman et al. May 2017 B2
9668784 Brumfield et al. Jun 2017 B2
9668876 Blain et al. Jun 2017 B2
9668879 Jimenez et al. Jun 2017 B2
9675465 Padovani et al. Jun 2017 B2
9675467 Duffield et al. Jun 2017 B2
9675468 Jensen Jun 2017 B1
9693871 Richerme et al. Jul 2017 B2
9700428 Niemiec et al. Jul 2017 B2
9707092 Davenport et al. Jul 2017 B2
9713536 Foley et al. Jul 2017 B2
9717601 Miller Aug 2017 B2
9730684 Beale et al. Aug 2017 B2
9730806 Capote Aug 2017 B2
9737288 Karpowicz et al. Aug 2017 B2
9750617 Lim et al. Sep 2017 B2
9750618 Daffinson et al. Sep 2017 B1
9757249 Radcliffe et al. Sep 2017 B2
9763722 Roybal Sep 2017 B2
9770343 Weiman Sep 2017 B2
9782265 Weiman et al. Oct 2017 B2
9788971 Stein Oct 2017 B1
9795370 O'Connell et al. Oct 2017 B2
9795371 Miles et al. Oct 2017 B2
9801733 Wolters et al. Oct 2017 B2
9801734 Stein et al. Oct 2017 B1
9808352 Suddaby et al. Nov 2017 B2
9826966 Mast et al. Nov 2017 B2
9827024 Cormier et al. Nov 2017 B2
9827107 Amin Nov 2017 B1
9833333 Duffield et al. Dec 2017 B2
9833336 Davenport et al. Dec 2017 B2
9839527 Robinson Dec 2017 B2
9839528 Weiman et al. Dec 2017 B2
9848993 Moskowitz et al. Dec 2017 B2
9848996 Faulhaber Dec 2017 B2
9855151 Weiman Jan 2018 B2
9867715 McLaughlin et al. Jan 2018 B2
9872779 Miller et al. Jan 2018 B2
9889019 Rogers et al. Feb 2018 B2
9907671 Fessler Mar 2018 B2
9907673 Weiman et al. Mar 2018 B2
9918709 Sandhu Mar 2018 B2
9924859 Lee et al. Mar 2018 B2
9924940 Moskowitz et al. Mar 2018 B2
9925062 Glerum et al. Mar 2018 B2
9925064 Duffield et al. Mar 2018 B2
9931223 Cain Apr 2018 B2
9937053 Melkent et al. Apr 2018 B2
9937060 Fuhrer et al. Apr 2018 B2
9943342 Tanaka et al. Apr 2018 B2
9943418 Davenport et al. Apr 2018 B2
9949775 Reed et al. Apr 2018 B2
9949841 Glerum et al. Apr 2018 B2
9956087 Seifert et al. May 2018 B2
9962202 Anderson May 2018 B2
9962270 Alheidt et al. May 2018 B2
9962271 Glerum May 2018 B2
9962272 Daffinson et al. May 2018 B1
9968461 Zappacosta et al. May 2018 B2
9968462 Weiman May 2018 B2
9974531 Miles et al. May 2018 B2
9974662 Hessler et al. May 2018 B2
9974664 Emerick et al. May 2018 B2
9980825 Nichols et al. May 2018 B2
9980826 Martynova et al. May 2018 B2
9987141 Duffield et al. Jun 2018 B2
9987143 Robinson et al. Jun 2018 B2
9987144 Seifert et al. Jun 2018 B2
9987146 Lentner et al. Jun 2018 B1
9993239 Karpowicz et al. Jun 2018 B2
9993350 Cain Jun 2018 B2
10004607 Weiman et al. Jun 2018 B2
10004608 Carnes et al. Jun 2018 B2
10016282 Seifert et al. Jul 2018 B2
10016284 Moskowitz et al. Jul 2018 B2
10022239 Lentner et al. Jul 2018 B1
10028842 Gray et al. Jul 2018 B2
10034765 Blain et al. Jul 2018 B2
10034769 Baynham Jul 2018 B2
10034771 Capote et al. Jul 2018 B2
10034772 Glerum et al. Jul 2018 B2
10034773 McLaughlin et al. Jul 2018 B2
10039539 Friedrich et al. Aug 2018 B2
10039650 Lamborne et al. Aug 2018 B2
10052214 Jimenez et al. Aug 2018 B2
10058431 Tyber et al. Aug 2018 B2
10060469 Jimenez et al. Aug 2018 B2
10070852 Mast et al. Sep 2018 B2
10076320 Mast et al. Sep 2018 B2
10076423 Miller et al. Sep 2018 B2
10080666 Suddaby et al. Sep 2018 B2
10080669 Davenport et al. Sep 2018 B2
10085846 Grotz Oct 2018 B2
10085849 Weiman et al. Oct 2018 B2
10092417 Weiman et al. Oct 2018 B2
10098758 Matthews et al. Oct 2018 B2
10098759 Weiman Oct 2018 B2
10111755 Foley et al. Oct 2018 B2
10111758 Robinson Oct 2018 B2
10117754 Davenport et al. Nov 2018 B2
10117755 Emerick et al. Nov 2018 B2
10137002 Padovani et al. Nov 2018 B2
10137006 Dewey et al. Nov 2018 B2
10137007 Dewey et al. Nov 2018 B2
10137009 Weiman et al. Nov 2018 B2
10149671 Predick et al. Dec 2018 B2
10149710 Tanaka et al. Dec 2018 B2
10154781 Weiman Dec 2018 B2
10154912 Glerum Dec 2018 B2
10154914 Robinson Dec 2018 B2
10159584 Carnes et al. Dec 2018 B2
10166117 Daffinson et al. Jan 2019 B1
10172515 Lee et al. Jan 2019 B2
10172652 Woolley et al. Jan 2019 B2
10178987 Predick et al. Jan 2019 B2
10179053 Zappacosta et al. Jan 2019 B2
10182922 Nichols et al. Jan 2019 B2
10188527 Rogers et al. Jan 2019 B2
10195050 Palmatier et al. Feb 2019 B2
10201431 Slater et al. Feb 2019 B2
10213192 Capote Feb 2019 B2
10213193 Karpowicz et al. Feb 2019 B2
10219798 Capote Mar 2019 B2
10219913 Matthews et al. Mar 2019 B2
10219914 Faulhaber Mar 2019 B2
10219915 Stein Mar 2019 B1
10226356 Grotz Mar 2019 B2
10226359 Glerum et al. Mar 2019 B2
10238375 O'Connell et al. Mar 2019 B2
10238383 Moskowitz et al. Mar 2019 B2
10238503 Branch et al. Mar 2019 B2
10245015 Predick et al. Apr 2019 B2
10251643 Moskowitz et al. Apr 2019 B2
10265191 Lim et al. Apr 2019 B2
10278686 Baudouin et al. May 2019 B2
10278786 Friedrich et al. May 2019 B2
10278830 Walker et al. May 2019 B1
10278831 Sandul May 2019 B2
10278832 Nichols et al. May 2019 B2
10285680 Friedrich et al. May 2019 B2
10285819 Greenhalgh May 2019 B2
10285824 Robinson May 2019 B2
10292828 Greenhalgh May 2019 B2
10299777 Mast et al. May 2019 B2
10299934 Seifert et al. May 2019 B2
10299937 McAfee May 2019 B2
10307268 Moskowitz et al. Jun 2019 B2
10314622 Brumfield et al. Jun 2019 B2
10314719 Hessler et al. Jun 2019 B2
10322007 Masson et al. Jun 2019 B2
10322009 Aghayev et al. Jun 2019 B2
10327909 Baynham Jun 2019 B2
10327912 Suddaby Jun 2019 B1
10327917 Glerum et al. Jun 2019 B2
10342675 Alheidt Jul 2019 B2
10350085 Glerum et al. Jul 2019 B2
10357233 Miles et al. Jul 2019 B2
10363142 McClintock et al. Jul 2019 B2
10363144 Overes et al. Jul 2019 B2
10369004 Faulhaber Aug 2019 B2
10369008 Jimenez et al. Aug 2019 B2
10369010 Robinson et al. Aug 2019 B2
10369012 Fessler Aug 2019 B2
10376377 Seifert et al. Aug 2019 B2
10390962 Weiman Aug 2019 B2
10390964 Faulhaber Aug 2019 B2
10398563 Engstrom Sep 2019 B2
10398566 Olmos et al. Sep 2019 B2
10413419 Thibodeau Sep 2019 B2
10413422 Flower et al. Sep 2019 B2
10413423 Overes et al. Sep 2019 B2
10426450 Vogel et al. Oct 2019 B2
10426633 Moskowitz et al. Oct 2019 B2
10426634 Al-Jazaeri et al. Oct 2019 B1
10441430 Ludwig et al. Oct 2019 B2
10449056 Cain Oct 2019 B2
10456122 Koltz et al. Oct 2019 B2
10470894 Foley et al. Nov 2019 B2
10478319 Moskowitz et al. Nov 2019 B2
10492912 Gregersen et al. Dec 2019 B2
10492922 Mathieu et al. Dec 2019 B2
10492924 Stein et al. Dec 2019 B2
10500064 Robinson Dec 2019 B2
10512550 Bechtel et al. Dec 2019 B2
10517645 van der Pol Dec 2019 B2
10524924 Davenport et al. Jan 2020 B2
10531903 Daly et al. Jan 2020 B2
10537436 Maguire et al. Jan 2020 B2
10537438 Martynova et al. Jan 2020 B2
10555729 Cole et al. Feb 2020 B1
10561411 Cole et al. Feb 2020 B1
10575889 Roybal Mar 2020 B2
10575960 Duffield et al. Mar 2020 B2
10582959 Langer et al. Mar 2020 B2
10583015 Olmos et al. Mar 2020 B2
10603078 Simpson et al. Mar 2020 B2
10610376 Kuyler et al. Apr 2020 B2
10624757 Bost et al. Apr 2020 B2
10624758 Slivka et al. Apr 2020 B2
10624761 Davenport et al. Apr 2020 B2
10639163 Tyber et al. May 2020 B2
10639166 Weiman et al. May 2020 B2
10653458 Tanaka et al. May 2020 B2
10667925 Emerick et al. Jun 2020 B2
10667927 Lamborne et al. Jun 2020 B2
10675157 Zakelj et al. Jun 2020 B2
10682241 Glerum et al. Jun 2020 B2
10687963 Jimenez et al. Jun 2020 B2
10702393 Davenport et al. Jul 2020 B2
10709569 McLaughlin et al. Jul 2020 B2
10709571 Iott et al. Jul 2020 B2
10709572 Daffinson et al. Jul 2020 B2
10709575 Robinson Jul 2020 B2
10722377 Glerum et al. Jul 2020 B2
10722379 McLaughlin et al. Jul 2020 B2
10729561 Glerum Aug 2020 B2
10743858 Cole et al. Aug 2020 B1
10744002 Glerum et al. Aug 2020 B2
10758366 Daffinson et al. Sep 2020 B2
10758367 Weiman et al. Sep 2020 B2
10758369 Rogers et al. Sep 2020 B2
10765528 Weiman et al. Sep 2020 B2
10772737 Gray et al. Sep 2020 B2
10779955 Kuyler et al. Sep 2020 B2
10779957 Weiman et al. Sep 2020 B2
10786364 Davenport et al. Sep 2020 B2
10786369 Carnes et al. Sep 2020 B2
10799368 Glerum et al. Oct 2020 B2
10835387 Weiman et al. Nov 2020 B2
10842640 Weiman et al. Nov 2020 B2
10842644 Weiman et al. Nov 2020 B2
10856997 Cowan et al. Dec 2020 B2
10869769 Eisen et al. Dec 2020 B2
10874447 Tanaka et al. Dec 2020 B2
10874522 Weiman Dec 2020 B2
10874523 Weiman et al. Dec 2020 B2
10874524 Bjork Dec 2020 B2
10881524 Eisen et al. Jan 2021 B2
10881531 Berry Jan 2021 B2
10888431 Robinson Jan 2021 B1
10898344 Alheidt et al. Jan 2021 B2
10898346 Suddaby Jan 2021 B1
10925656 Cole et al. Feb 2021 B2
10925750 Zappacosta et al. Feb 2021 B2
10925752 Weiman Feb 2021 B2
10932920 Dewey et al. Mar 2021 B2
10940014 Greenhalgh Mar 2021 B2
10945858 Bechtel et al. Mar 2021 B2
10952866 Warren et al. Mar 2021 B2
10959855 Miller et al. Mar 2021 B2
10959856 Seifert et al. Mar 2021 B2
10973649 Weiman et al. Apr 2021 B2
10973650 Stein Apr 2021 B2
10980642 Glerum et al. Apr 2021 B2
10980644 Purcell et al. Apr 2021 B2
10993814 Wolters May 2021 B2
11007067 Masson et al. May 2021 B2
11013617 Weiman et al. May 2021 B2
11020238 Nichols et al. Jun 2021 B2
11020239 Miller et al. Jun 2021 B2
11026804 Jimenez et al. Jun 2021 B2
11026812 Daffinson et al. Jun 2021 B2
11033401 Shoshtaev Jun 2021 B2
11033402 Melkent et al. Jun 2021 B2
11033404 Faulhaber Jun 2021 B2
11039935 McAfee Jun 2021 B2
11045326 Seifert et al. Jun 2021 B2
11045327 Nichols et al. Jun 2021 B2
11051949 Walker et al. Jul 2021 B2
11051951 Robinson et al. Jul 2021 B2
11058469 Mahajan et al. Jul 2021 B2
11065127 Lentner et al. Jul 2021 B1
11065129 Sandul Jul 2021 B2
11065130 Branch et al. Jul 2021 B2
11076966 Faulhaber Aug 2021 B2
11083584 Lauf et al. Aug 2021 B2
11083595 Robinson Aug 2021 B2
11090167 Emerick et al. Aug 2021 B2
11096795 Padovani et al. Aug 2021 B2
11096797 Moskowitz et al. Aug 2021 B2
11103366 Glerum et al. Aug 2021 B2
RE48719 Suddaby et al. Sep 2021 E
11109980 Seifert et al. Sep 2021 B2
11116644 Marrocco et al. Sep 2021 B2
11123198 Black et al. Sep 2021 B2
11123200 Faulhaber Sep 2021 B2
11129731 Miller et al. Sep 2021 B2
11135071 Dewey et al. Oct 2021 B2
11147680 Tyber et al. Oct 2021 B2
11154404 Freedman et al. Oct 2021 B2
11160666 Burkhardt et al. Nov 2021 B2
11160669 Rogers et al. Nov 2021 B2
11166826 Huang Nov 2021 B2
11173044 Jones et al. Nov 2021 B1
11179234 Dacosta et al. Nov 2021 B2
11285014 Josse et al. Mar 2022 B1
11376134 Dewey et al. Jul 2022 B1
11617658 Josse et al. Apr 2023 B2
11723780 Seifert et al. Aug 2023 B2
11737892 Kadaba et al. Aug 2023 B1
12064354 Robinson et al. Aug 2024 B2
20020045943 Uk Apr 2002 A1
20020045945 Liu et al. Apr 2002 A1
20020055741 Schlapfer et al. May 2002 A1
20020116066 Chauvin et al. Aug 2002 A1
20020128713 Ferree Sep 2002 A1
20020151976 Foley et al. Oct 2002 A1
20020183762 Anderson et al. Dec 2002 A1
20030050701 Michelson Mar 2003 A1
20030130739 Gerbec et al. Jul 2003 A1
20030163132 Chin Aug 2003 A1
20040102778 Huebner et al. May 2004 A1
20040172134 Berry Sep 2004 A1
20040186570 Rapp Sep 2004 A1
20040193158 Lim et al. Sep 2004 A1
20040204713 Abdou Oct 2004 A1
20040249461 Ferree Dec 2004 A1
20040254643 Jackson Dec 2004 A1
20040254644 Taylor Dec 2004 A1
20050015149 Michelson Jan 2005 A1
20050033429 Kuo Feb 2005 A1
20050033439 Gordon et al. Feb 2005 A1
20050147478 Greenberg Jul 2005 A1
20050154459 Wolek Jul 2005 A1
20050209698 Gordon et al. Sep 2005 A1
20050228398 Rathbun et al. Oct 2005 A1
20060122701 Kiester Jun 2006 A1
20060129244 Ensign Jun 2006 A1
20060260446 Chang Nov 2006 A1
20060276901 Zipnick et al. Dec 2006 A1
20070173840 Huebner Jul 2007 A1
20070218750 Corrao et al. Sep 2007 A1
20070233150 Blain et al. Oct 2007 A1
20070270859 Companioni et al. Nov 2007 A1
20080058804 Lechot et al. Mar 2008 A1
20080132959 Mikkonen et al. Jun 2008 A1
20080140207 Olmos et al. Jun 2008 A1
20090024158 Viker Jan 2009 A1
20090093830 Miller Apr 2009 A1
20090105834 Hovda Apr 2009 A1
20090292361 Lopez Nov 2009 A1
20100070035 Mayer Mar 2010 A1
20100076440 Pamichev et al. Mar 2010 A1
20100082109 Greenhalgh et al. Apr 2010 A1
20100152853 Kirschman Jun 2010 A1
20100191336 Greenhalgh Jul 2010 A1
20100211176 Greenhalgh Aug 2010 A1
20100280617 Coppes et al. Nov 2010 A1
20100286777 Errico et al. Nov 2010 A1
20110118843 Mathieu et al. May 2011 A1
20110130838 Morgenstern Lopez Jun 2011 A1
20110153020 Abdelgany et al. Jun 2011 A1
20110218572 Lechmann et al. Sep 2011 A1
20110218631 Woodburn, Sr. et al. Sep 2011 A1
20110301577 Simmen et al. Dec 2011 A1
20120004732 Goel et al. Jan 2012 A1
20120095515 Hamilton Apr 2012 A1
20120101581 Mathieu et al. Apr 2012 A1
20120109142 Dayan May 2012 A1
20120109309 Mathieu et al. May 2012 A1
20120109310 Mathieu et al. May 2012 A1
20120109312 Mathieu et al. May 2012 A1
20120109313 Mathieu et al. May 2012 A1
20120123546 Medina May 2012 A1
20120143195 Sander Jun 2012 A1
20120150237 Combrowski Jun 2012 A1
20120197401 Duncan et al. Aug 2012 A1
20120209385 Aferzon Aug 2012 A1
20120215313 Saidha et al. Aug 2012 A1
20120215316 Mohr et al. Aug 2012 A1
20130103095 Brumfield et al. Apr 2013 A1
20130158664 Palmatier et al. Jun 2013 A1
20130184823 Malberg Jul 2013 A1
20130190876 Drochner et al. Jul 2013 A1
20130211526 Alheidt et al. Aug 2013 A1
20130226191 Thoren et al. Aug 2013 A1
20130231747 Olmos et al. Sep 2013 A1
20130274557 Bowman et al. Oct 2013 A1
20130304136 Gourlaouen-Preissler et al. Nov 2013 A1
20130317312 Eastlack et al. Nov 2013 A1
20140018816 Fenn et al. Jan 2014 A1
20140107790 Combrowski Apr 2014 A1
20140114321 Davenport et al. Apr 2014 A1
20140114420 Robinson Apr 2014 A1
20140148904 Robinson May 2014 A1
20140163682 Iott et al. Jun 2014 A1
20140180419 Dmuschewsky Jun 2014 A1
20140194992 Medina Jul 2014 A1
20140249629 Moskowitz et al. Sep 2014 A1
20140249631 Weiman Sep 2014 A1
20140277471 Gray et al. Sep 2014 A1
20140277473 Perrow Sep 2014 A1
20140277487 Davenport et al. Sep 2014 A1
20140277500 Logan et al. Sep 2014 A1
20140303674 Sasing Oct 2014 A1
20140364855 Stoll et al. Dec 2014 A1
20150173915 Laubert et al. Jun 2015 A1
20150223945 Weiman et al. Aug 2015 A1
20150230931 Greenhalgh Aug 2015 A1
20150238236 Sasing Aug 2015 A1
20150354635 McClymont et al. Dec 2015 A1
20150374507 Wolters et al. Dec 2015 A1
20160008924 Canourgues et al. Jan 2016 A1
20160022434 Robinson Jan 2016 A1
20160051373 Faulhaber Feb 2016 A1
20160058571 McLaughlin et al. Mar 2016 A1
20160081681 Waugh et al. Mar 2016 A1
20160089247 Nichols et al. Mar 2016 A1
20160095710 Juszczyk et al. Apr 2016 A1
20160095718 Burkhardt et al. Apr 2016 A1
20160100951 Suddaby et al. Apr 2016 A1
20160128847 Kurtaliaj et al. May 2016 A1
20160199073 Nino et al. Jul 2016 A1
20160242930 Duffield et al. Aug 2016 A1
20160256291 Miller Sep 2016 A1
20160278830 Arrington Sep 2016 A1
20160296340 Gordon et al. Oct 2016 A1
20160310291 Greenhalgh Oct 2016 A1
20160345952 Kucharzyk et al. Dec 2016 A1
20160367377 Faulhaber Dec 2016 A1
20170010025 Mayershofer Jan 2017 A1
20170029635 Doll et al. Feb 2017 A1
20170035406 Abidin et al. Feb 2017 A1
20170049651 Lim et al. Feb 2017 A1
20170049653 Lim et al. Feb 2017 A1
20170095345 Davenport et al. Apr 2017 A1
20170100255 Hleihil et al. Apr 2017 A1
20170100257 Weiman et al. Apr 2017 A1
20170105844 Kuyler et al. Apr 2017 A1
20170112630 Kuyler et al. Apr 2017 A1
20170151065 Warren et al. Jun 2017 A1
20170156882 Rathbun et al. Jun 2017 A1
20170156884 Rathbun et al. Jun 2017 A1
20170189200 Miller et al. Jul 2017 A1
20170189204 Riemhofer et al. Jul 2017 A1
20170202678 Duffield et al. Jul 2017 A1
20170215856 Martinelli et al. Aug 2017 A1
20170224502 Wolters et al. Aug 2017 A1
20170224504 Butler et al. Aug 2017 A1
20170231675 Combrowski Aug 2017 A1
20170231780 D'Urso Aug 2017 A1
20170246006 Carnes et al. Aug 2017 A1
20170290677 Olmos et al. Oct 2017 A1
20170296352 Richerme et al. Oct 2017 A1
20170333200 Arnin Nov 2017 A1
20170367842 Predick et al. Dec 2017 A1
20170367843 Eisen et al. Dec 2017 A1
20170367844 Eisen et al. Dec 2017 A1
20170367845 Eisen et al. Dec 2017 A1
20180000606 Hessler et al. Jan 2018 A1
20180030362 Kosler et al. Feb 2018 A1
20180031810 Hsu et al. Feb 2018 A1
20180036136 Duffield et al. Feb 2018 A1
20180036138 Robinson Feb 2018 A1
20180104066 Bae et al. Apr 2018 A1
20180116819 Maguire et al. May 2018 A1
20180116891 Beale et al. May 2018 A1
20180193160 Hsu et al. Jul 2018 A1
20180193164 Shoshtaev Jul 2018 A1
20180206999 Suddaby Jul 2018 A1
20180256356 Robinson et al. Sep 2018 A1
20180256359 Greenhalgh Sep 2018 A1
20180256360 Cain Sep 2018 A1
20180256362 Slivka et al. Sep 2018 A1
20180263784 Bechtel et al. Sep 2018 A1
20180271513 Perrow et al. Sep 2018 A1
20180280142 Schultz et al. Oct 2018 A1
20180303473 Spann et al. Oct 2018 A1
20180303621 Brotman et al. Oct 2018 A1
20180303625 Alheidt et al. Oct 2018 A1
20180311048 Glerum et al. Nov 2018 A1
20180318101 Engstrom Nov 2018 A1
20180318102 Seifert et al. Nov 2018 A1
20180325574 Bjork et al. Nov 2018 A1
20180338838 Cryder et al. Nov 2018 A1
20180338841 Miller et al. Nov 2018 A1
20180344307 Hynes et al. Dec 2018 A1
20180360616 Luu Dec 2018 A1
20190000640 Weiman Jan 2019 A1
20190000702 Lim et al. Jan 2019 A1
20190000707 Lim et al. Jan 2019 A1
20190020121 Paulotto et al. Jan 2019 A1
20190021716 Waugh et al. Jan 2019 A1
20190021873 Dmuschewsky Jan 2019 A1
20190046329 Padovani et al. Feb 2019 A1
20190046381 Lim et al. Feb 2019 A1
20190046383 Lim et al. Feb 2019 A1
20190060083 Weiman et al. Feb 2019 A1
20190082949 Weiman Mar 2019 A1
20190083081 Ortiz et al. Mar 2019 A1
20190091033 Dewey et al. Mar 2019 A1
20190105175 Zappacosta et al. Apr 2019 A1
20190125328 Blain May 2019 A1
20190133434 Lee et al. May 2019 A1
20190133645 Gordon et al. May 2019 A1
20190133779 McLaughlin et al. May 2019 A1
20190133780 Matthews et al. May 2019 A1
20190133784 Gunn et al. May 2019 A1
20190133788 Weiman et al. May 2019 A1
20190142480 Woolley et al. May 2019 A1
20190151115 Nichols et al. May 2019 A1
20190183656 Stein Jun 2019 A1
20190201209 Branch et al. Jul 2019 A1
20190201210 Besaw et al. Jul 2019 A1
20190209155 Mast et al. Jul 2019 A1
20190216453 Predick et al. Jul 2019 A1
20190231552 Sandul Aug 2019 A1
20190240039 Walker et al. Aug 2019 A1
20190240043 Greenhalgh Aug 2019 A1
20190247098 Brumfield et al. Aug 2019 A1
20190254650 Martinelli et al. Aug 2019 A1
20190254838 Miller et al. Aug 2019 A1
20190254839 Nichols et al. Aug 2019 A1
20190262009 Cheng Aug 2019 A1
20190262139 Wolters Aug 2019 A1
20190269521 Shoshtaev Sep 2019 A1
20190274670 O'Connell et al. Sep 2019 A1
20190274671 Lauf et al. Sep 2019 A1
20190274836 Eisen et al. Sep 2019 A1
20190282373 Alheidt Sep 2019 A1
20190290446 Masson et al. Sep 2019 A1
20190290447 Stein Sep 2019 A1
20190298416 Rezach Oct 2019 A1
20190298524 Lauf et al. Oct 2019 A1
20190298540 Aghayev et al. Oct 2019 A1
20190321022 Karpowicz et al. Oct 2019 A1
20190321190 Wagner et al. Oct 2019 A1
20190328539 Suh et al. Oct 2019 A1
20190328540 Seifert et al. Oct 2019 A1
20190329388 Erickson et al. Oct 2019 A1
20190336301 Engstrom Nov 2019 A1
20190336304 Burkhardt et al. Nov 2019 A1
20190350573 Vogel et al. Nov 2019 A1
20190358049 Faulhaber Nov 2019 A1
20190358050 Fessler Nov 2019 A1
20190358051 Flower et al. Nov 2019 A1
20190380840 Tyber et al. Dec 2019 A1
20190388232 Purcell et al. Dec 2019 A1
20200008951 McClintock et al. Jan 2020 A1
20200030114 Cain Jan 2020 A1
20200030116 Jimenez et al. Jan 2020 A1
20200038200 Foley et al. Feb 2020 A1
20200054461 Marrocco et al. Feb 2020 A1
20200060844 Mathieu et al. Feb 2020 A1
20200069316 DeSoutter et al. Mar 2020 A1
20200078190 Rogers et al. Mar 2020 A1
20200093526 Daly et al. Mar 2020 A1
20200093607 Davenport et al. Mar 2020 A1
20200093609 Shoshtaev Mar 2020 A1
20200100904 Stein et al. Apr 2020 A1
20200107824 Fleischer Apr 2020 A1
20200129306 Miller et al. Apr 2020 A1
20200129307 Hunziker et al. Apr 2020 A1
20200138591 Moskowitz et al. May 2020 A1
20200138593 Martynova et al. May 2020 A1
20200146840 Black et al. May 2020 A1
20200179120 Bielenstein et al. Jun 2020 A1
20200205993 Davenport et al. Jul 2020 A1
20200214754 Bowen et al. Jul 2020 A1
20200222202 Kuyler et al. Jul 2020 A1
20200229944 Suh et al. Jul 2020 A1
20200246159 Suh et al. Aug 2020 A1
20200246162 Schultz et al. Aug 2020 A1
20200261242 Bost et al. Aug 2020 A1
20200268524 Glerum et al. Aug 2020 A1
20200276028 Blain et al. Sep 2020 A1
20200281741 Grotz Sep 2020 A1
20200289287 Emerick et al. Sep 2020 A1
20200297507 Iott et al. Sep 2020 A1
20200330239 Davenport et al. Oct 2020 A1
20200330245 Glerum Oct 2020 A1
20200345511 Daffinson et al. Nov 2020 A1
20200352731 Berry Nov 2020 A1
20200352738 Berry Nov 2020 A1
20200360153 Weiman et al. Nov 2020 A1
20200375753 McLaughlin et al. Dec 2020 A1
20200375755 Cain Dec 2020 A1
20200383797 Predick et al. Dec 2020 A1
20200383799 Cain Dec 2020 A1
20200390433 Yu et al. Dec 2020 A1
20200390565 Jimenez et al. Dec 2020 A1
20200397593 Davenport et al. Dec 2020 A1
20200405497 Olmos et al. Dec 2020 A1
20200405498 Gray et al. Dec 2020 A1
20200405499 Gerbec et al. Dec 2020 A1
20200405500 Cain Dec 2020 A1
20210007860 Glerum et al. Jan 2021 A1
20210015626 Suddaby Jan 2021 A1
20210030555 Weiman et al. Feb 2021 A1
20210030561 Gleason Feb 2021 A1
20210045891 Rogers et al. Feb 2021 A1
20210045892 Rogers et al. Feb 2021 A1
20210052395 Iott et al. Feb 2021 A1
20210068959 McLuen et al. Mar 2021 A1
20210068974 Cowan et al. Mar 2021 A1
20210068982 Carnes et al. Mar 2021 A1
20210077271 Sharabani Mar 2021 A1
20210077272 Eisen et al. Mar 2021 A1
20210085479 Weiman et al. Mar 2021 A1
20210093462 Lucasiewicz et al. Apr 2021 A1
20210106434 Alheidt et al. Apr 2021 A1
20210113349 Weiman et al. Apr 2021 A1
20210121299 Hyder Apr 2021 A1
20210121300 Weiman et al. Apr 2021 A1
20210137697 Weiman May 2021 A1
20210137699 Jang et al. May 2021 A1
20210137701 Miller et al. May 2021 A1
20210154811 Spreiter et al. May 2021 A1
20210161678 Dewey et al. Jun 2021 A1
20210177618 Branch et al. Jun 2021 A1
20210186706 Spitler et al. Jun 2021 A1
20210186709 Weiman et al. Jun 2021 A1
20210196470 Shoshtaev Jul 2021 A1
20210205092 Glerum et al. Jul 2021 A1
20210205094 Neiman et al. Jul 2021 A1
20210220145 Stein Jul 2021 A1
20210220147 Berry Jul 2021 A1
20210236298 Weiman et al. Aug 2021 A1
20210251770 Purcell et al. Aug 2021 A1
20210251776 Daffinson et al. Aug 2021 A1
20210259848 Kang et al. Aug 2021 A1
20210259849 Robinson et al. Aug 2021 A1
20210259850 Eisen et al. Aug 2021 A1
20210267767 Stein Sep 2021 A1
20210275317 Spetzger Sep 2021 A1
20210275318 Reimels Sep 2021 A1
20210275319 Reimels Sep 2021 A1
20210275321 Seifert et al. Sep 2021 A1
20210282938 Nichols et al. Sep 2021 A1
20210298915 Faulhaber Sep 2021 A1
20210298916 Melkent et al. Sep 2021 A1
20210307920 Walker et al. Oct 2021 A1
20210315705 Altarac et al. Oct 2021 A1
20210322179 Miller et al. Oct 2021 A1
20210322181 Predick Oct 2021 A1
20210322182 Faulhaber Oct 2021 A1
20210330472 Shoshtaev Oct 2021 A1
20210346174 Flint et al. Nov 2021 A1
20210401586 Zakelj Dec 2021 A1
20220015924 Freedman et al. Jan 2022 A1
20220047312 Seykora et al. Feb 2022 A1
20220087819 Robinson et al. Mar 2022 A1
20220133336 Tsai et al. May 2022 A1
20220133497 Dewey et al. May 2022 A1
20220133498 Josse et al. May 2022 A1
20220133499 Josse et al. May 2022 A1
20220218325 Josse Jul 2022 A1
20220313450 Donohoe et al. Oct 2022 A1
20220387184 Josse et al. Dec 2022 A1
20220409397 Hayes et al. Dec 2022 A1
20230015512 Eisen et al. Jan 2023 A1
20230027836 Predick et al. Jan 2023 A1
20230137358 Hayes et al. May 2023 A1
Foreign Referenced Citations (38)
Number Date Country
107 137 166 Sep 2017 CN
44 16 605 Jun 1995 DE
0 767 636 Apr 1997 EP
0 880 950 Dec 1998 EP
0 857 042 Nov 2001 EP
1 442 732 Aug 2004 EP
1 124 512 Sep 2004 EP
1 107 711 Oct 2004 EP
1 506 753 Feb 2005 EP
1 459 711 Jul 2007 EP
2954860 Dec 2015 EP
3031424 Jun 2016 EP
3 069 694 Sep 2016 EP
3213720 Sep 2017 EP
2781998 Feb 2000 FR
3082115 Dec 2019 FR
2 377 387 Jan 2003 GB
102192022 Dec 2020 KR
9214423 Sep 1992 WO
97 00054 Jan 1997 WO
99 26562 Jun 1999 WO
9966867 Dec 1999 WO
0012033 Mar 2000 WO
0025706 May 2000 WO
00 49977 Aug 2000 WO
WO-0074608 Dec 2000 WO
0219952 Mar 2002 WO
03105673 Dec 2003 WO
2006116850 Nov 2006 WO
2012139022 Oct 2012 WO
2014133755 Sep 2014 WO
2015063721 May 2015 WO
2015198335 Dec 2015 WO
2016057940 Apr 2016 WO
2016205607 Dec 2016 WO
2017168208 Oct 2017 WO
2018049227 Mar 2018 WO
2021055323 Mar 2021 WO
Non-Patent Literature Citations (14)
Entry
International Search Report and Written Opinion in Application No. PCT/IB2023/058417 dated Dec. 7, 2023.
International Search Report and Written Opinion in Application No. PCT/US2022/016831 dated Sep. 29, 2022.
International Search Report, and Written Opinion for Application. No. PCT/US2019/019067, dated Jun. 3, 2019.
International Search Report and Written Opinion for Application No. PCT/US2019/019060, dated Jun. 5, 2019.
Chinese Office Action in Application No. 201980010758.4 dated Sep. 16, 2023.
International Search Report and Written Opinion in Application No. PCT/US2022/027200 dated Aug. 19, 2022.
International Search Report and Written Opinion, PCT/IB2020/000942, Dated Aug. 10, 2021.
International Search Report and Written Opinion in Application No. PCT/US2022/016809 dated Jul. 27, 2022.
International Search Report and Written Opinion in Application No. PCT/US2022/027695 dated Jul. 27, 2022.
International Search Report and Written Opinion, PCT/IB2020/000932, Dated Jul. 29, 2021.
Chinese Office Action in Application No. 201980010758.4 dated Jun. 16, 2023.
International Search Report and Written Opinion in Application No. PCT/US2022/030094 dated Sep. 16, 2022.
International Search Report and Written Opinion in Application No. PCT/IB2023/057720 dated Nov. 8, 2023.
International Search Report and Written Opinion in Application No. PCT/IB2024/054985 dated Sep. 10, 2024.
Related Publications (1)
Number Date Country
20220133488 A1 May 2022 US
Continuation in Parts (4)
Number Date Country
Parent 17331058 May 2021 US
Child 17332284 US
Parent 17307578 May 2021 US
Child 17332284 US
Parent 17246968 May 2021 US
Child 17332284 US
Parent 17123889 Dec 2020 US
Child 17331058 US